Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM)
Market Closed
11 Aug, 22:00
MSE XNSE Primary MSE ₹
231. 00
-3
-1.2821%
₹
- Market Cap
34.78 P/E Ratio
10% Div Yield
588 Volume
0 Eps
₹ 234
Previous Close Want to track JAGSNPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Statistics
Valuation metrics
Market Cap -
Enterprise value 15.22B
Trailing P/E (ttm) 34
Forward P/E -
PEG ratio -1.37
Price/Sales (ttm) 5.18
Price/Book (mrq) 5.51
Enterprise Value/Revenue 5.18
Enterprise Value/EBITDA 22.32
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 76.53K
Average volume (90 days) 18.71K
Price summary
52-Week low 154.9
52-Week high 264.65
Beta -
50-Day moving average 229.45
200-Day moving average 199.84
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.5
Trailing annual dividend yield 0.0108%
5-Year annual dividend yield -
Payout ratio 0.37
Dividend Date 24 Oct 2025
Ex-Dividend Date 12 Sep 2025
Last split factor 2:1
Last split Date 8 Jan 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.15%
Operating margin 0.18%
Operational effectiveness
Return on assets 0.14%
Return on equity 0.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 44.63
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 6.91
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 16.13
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 5.06%
Book value per share (mrq) 41.95
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
